Trial
NCT03062176
Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With Advanced Chronic Kidney Disease
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Virginia Commonwealth University
Collaborators
—
Condition
Heart Failure, Systolic
Intervention
Anakinra
Why stopped
We screened over 200 patients but were ultimately unable to enroll anyone
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-05-17